FDA applicant
Geneohm Sciences Canada, Inc. (Bd Diagnostics)
FDA records 4 decisions for Geneohm Sciences Canada, Inc. (Bd Diagnostics) (Quebec, CA) from 2013 to 2019: 3 510(k) clearances and 1 De Novo grant. Most are in product codes PQA (Vaginitis And Bacterial Vaginosis Nucleic Acid…) and NQX (System, Nucleic Acid Amplification Test, Dna…). Its devices cite 4 predicates, 1 of them its own earlier devices. 4 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Geneohm Sciences Canada, Inc. (Bd Diagnostics)’s devices, and how often a recall has named them.
FDA decisions per year
1in 2019
2026 so far, outlined.
Recalls per year
1in 2025
Class I Class II/III not classified
Planning a device like Geneohm Sciences Canada, Inc. (Bd…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Geneohm”
FDA records each applicant name separately; these may or may not be the same firm.